49
GENERA L PHA RMACOLOGY GENERA L PHA RMA COL OGY Dr . Hanan Hag ar  Dr. Hanan Hagar  MPHL MPHL - - 231 231

GENERAL PHARMACOLOGY -Part 1.pdf

Embed Size (px)

Citation preview

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 1/49

GENERAL PHARMACOLOGYGENERAL PHARMACOLOGY

Dr. Hanan Hagar Dr. Hanan Hagar MPHLMPHL -- 231231

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 2/49

Recommended booksRecommended books

Basic and Clinical PharmacologyBasic and Clinical Pharmacology

byby KatzungKatzung

PharmacologyPharmacology

byby RangRang

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 3/49

 Assessment of the course MPHL 231 Assessment of the course MPHL 231

CATCAT-- II ……………………………… 1010

MidMid--termterm……………………………….30.30CATCAT-- IIII…………………………………… 1515

PracticalPractical ……………………………… 55

------------------------TotalTotal 6060

FinalFinal 4040------------------------

100100

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 4/49

OUTLINESOUTLINES

Introduction to pharmacologyIntroduction to pharmacology

Branches of pharmacologyBranches of pharmacology

Pharmacokinetics.Pharmacokinetics.

Pharmacodynamics.Pharmacodynamics.

Drug nomenclature.Drug nomenclature.

Sources of DrugsSources of Drugs Adverse Drug Reactions Adverse Drug Reactions

DrugDrug--Drug interactionsDrug interactions

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 5/49

PharmacologyPharmacology

PharmakonPharmakon : drug: drug

Logos: ScienceLogos: Science

Is the science that deals with theIs the science that deals with thedrugs names, pharmacokinetics,drugs names, pharmacokinetics,

pharmacodynamicspharmacodynamics , side effects and, side effects anduses.uses.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 6/49

DrugDrug

DrugDrug = Drogue = a dry herb= Drogue = a dry herb

It is any chemical substance thatmodify physiological system ormodify physiological system or

pathological statepathological state and can be usedfor diagnosis, prevention or

treatment of disease.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 7/49

Pharmacology is divided into twoPharmacology is divided into two

parts:parts:

PharmacokineticsPharmacokinetics

What the body does to the drug?What the body does to the drug?

PharmacodynamicsPharmacodynamicsWhat the drug does to the body?What the drug does to the body?

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 8/49

PharmacokineticsPharmacokinetics

 Are studies of the absorption, Are studies of the absorption,

distribution, metabolism &distribution, metabolism &

excretion of drugs.excretion of drugs.

PharmacodynamicsPharmacodynamics

 Are studies of Are studies of-- Mechanisms of drug action.Mechanisms of drug action.

-- Pharmacological effects.Pharmacological effects.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 9/49

PharmacodynamicsPharmacodynamics

deals with the action of drugs ondeals with the action of drugs on

living cells and mechanisms byliving cells and mechanisms by

which such effects are produced.which such effects are produced.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 10/49

PharmacopiaPharmacopia

PharmakonPharmakon && PoieinPoiein..

PoieinPoiein means make.means make.

 A pharmacopia or formulary is the book A pharmacopia or formulary is the book

containing a list of drugs withcontaining a list of drugs withdescriptions and formulas which isdescriptions and formulas which is

published by authorized body.published by authorized body.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 11/49

British Pharmacopia (BP).British Pharmacopia (BP).

United States Pharmacopia (USP).United States Pharmacopia (USP).

British National Formulary (BNF).British National Formulary (BNF).

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 12/49

Drug nomenclatureDrug nomenclature

 –  –  Full chemical name (Full chemical name ( Acetyl Acetyl

salicylic acidsalicylic acid).).

 –  –  Official = Generic nameOfficial = Generic name((SalicylatesSalicylates).).

 –  –  Trade name (Trade name ( Aspro Aspro).).

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 13/49

Sources of DrugsSources of Drugs

Plants:Plants:

 –  –  Alkaloids (MorphineAlkaloids (Morphine--PilocarpinePilocarpine).).

 –  – Glycosides (Glycosides (digoxindigoxin).).

AnimalsAnimals: Insulin: Insulin--VaccinesVaccines--Vitamins.Vitamins.

Minerals:Minerals: Iron, gold,Iron, gold, aluminiumaluminium

salts.salts.

Synthetic:Synthetic: SulphonamidesSulphonamides--aspirin.aspirin.

Microorganisms:Microorganisms: Antibiotics.Antibiotics.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 14/49

 Animal Source: Animal Source:

 –  – Vitamin A from cod liver.Vitamin A from cod liver. –  – Insulin from pancreas of bovine orInsulin from pancreas of bovine or procineprocine..

Mineral Source:Mineral Source:

 –  – IodineIodine == Goiter.Goiter. –  – IronIron ==  Anaemia Anaemia..

 –  – GoldGold ==  Arthritis. Arthritis. –  –  Aluminum hydroxide and magnesium Aluminum hydroxide and magnesium

trisilicatetrisilicate asas antiacidsantiacids..

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 15/49

 Absorption Absorption of Drugsof Drugs

OUTLINEOUTLINE

Mechanisms of drug absorptionMechanisms of drug absorption

Routes of drug administrationRoutes of drug administration

Factors Affecting Drug absorptionFactors Affecting Drug absorption

BioavailabilityBioavailability Drug FormulationsDrug Formulations

PHARMACOKINETICS

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 16/49

Is the passage of drug through bodyIs the passage of drug through bodybarriers or cell membranes to reach itsbarriers or cell membranes to reach its

site of action.site of action.Mechanisms of drug absorptionMechanisms of drug absorption

1.1. Simple diffusion = passive diffusion.Simple diffusion = passive diffusion.2.2.  Active transport. Active transport.

3.3. Facilitated diffusion.Facilitated diffusion.4.4. PinocytosisPinocytosis (Endocytosis).(Endocytosis).

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 17/49

CharactersCharactersCommonest.Commonest.

Non selectiveNon selectiveRequires no energy.Requires no energy.

Depends on concentration gradient.Depends on concentration gradient.

Depends on Lipid/ Water partit ionDepends on Lipid/ Water partit ion

coefficient.coefficient.

Depends onDepends on pkapka of drug.of drug. Depends on pH of environment.Depends on pH of environment.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 18/49

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 19/49

PKaPKa(Dissociation or ionization constant)(Dissociation or ionization constant)

PH at which half of the substance isPH at which half of the substance isionized & half is unionized.ionized & half is unionized.

PHPH::

 –  – 

ionization of drugs.ionization of drugs.

 –  – Weak acidsWeak acids best absorbed in stomach.best absorbed in stomach.

 –  – Weak basesWeak bases best absorbed in intestine.best absorbed in intestine.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 20/49

Relatively unusual.Relatively unusual.Occurs against concentration gradient.Occurs against concentration gradient.

Requires carrier and energy.Requires carrier and energy.Specific e.g. Iodides.Specific e.g. Iodides.

Saturable.Saturable.Depends on Lipid/Water partitionDepends on Lipid/Water partition

coefficient.coefficient. Iron absorption.Iron absorption.

Uptake of levodopa by brain.Uptake of levodopa by brain.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 21/49

Occurs along concentration gradient.Occurs along concentration gradient.

Requires carriersRequires carriers

Selective.Selective.

Saturable.Saturable.

Does not require energy.Does not require energy.

Is independent of Lipid/WaterIs independent of Lipid/Water

partition coefficient.partition coefficient.

e.g. Uptake of glucose,e.g. Uptake of glucose, vitvit B12 &B12 &

intrinsic factor.intrinsic factor.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 22/49

High molecular weight drugsHigh molecular weight drugs

Engulfment of the substrate by the cell.Engulfment of the substrate by the cell.Vit A & D & E & K absorbed by this way.Vit A & D & E & K absorbed by this way.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 23/49

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 24/49

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 25/49

Gastrointestinal tract (GIT).Gastrointestinal tract (GIT).

 –  – OralOral

 –  – SublingualSublingual

 –  – RectalRectal

Parenteral administration = injections.Parenteral administration = injections.Topical applicationTopical application

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 26/49

Oral administrationOral administration

 Advantages AdvantagesEasyEasy

Self useSelf useSafeSafe

Most convenientMost convenient

cheap.cheap.

No need for sterilization.No need for sterilization.

Di d t f lDi d t f l

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 27/49

Disadvantages of oralDisadvantages of oral

 –  – Delayed effect (Slow effect).Delayed effect (Slow effect). –  – Not suitable for vomiting, unconscious,Not suitable for vomiting, unconscious,

emergency.emergency.

 –  – No complete absorption (LowNo complete absorption (Low

bioavailability).bioavailability).

 –  – Destruction by GIT.Destruction by GIT.

 –  – First pass effect.First pass effect.

 –  – GIT irritation.GIT irritation.

 –  – FoodFood – –Drug interactions.Drug interactions.

 –  – DrugDrug--Drug interactions.Drug interactions.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 28/49

FormulationFormulation

CapsulesCapsules

TabletsTablets

GranulesGranules

SyrupSyrup

SuspensionSuspensionEmulsionEmulsion

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 29/49

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 30/49

 Advantages Advantages

 –  – Rapid effect (Emergency)Rapid effect (Emergency) –  – No first pass metabolism.No first pass metabolism.

 –  – No destruction by GIT (PH).No destruction by GIT (PH). –  – No food drug interaction.No food drug interaction.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 31/49

DisadvantagesDisadvantages

 –  – Limited drugs.Limited drugs.

 –  – Smaller doses than oral.Smaller doses than oral. –  – Dosage form (friable tablets).Dosage form (friable tablets).

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 32/49

 –  – Not forNot for

irritant drugs.irritant drugs.

Frequent use.Frequent use. Vasoconstrictors forVasoconstrictors for buccalbuccal BVS.BVS.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 33/49

AdvantagesAdvantages

Suitable forSuitable for –  – vomiting & unconsciousness, children.vomiting & unconsciousness, children.

 –  – Irritant & Bad taste drugs.Irritant & Bad taste drugs.

 –  –  For Local action e.g. pilesFor Local action e.g. piles

 –  – Avoid first pass metabolism.Avoid first pass metabolism.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 34/49

DisadvantagesDisadvantages

 –  – Irregular absorption & bioavailability.Irregular absorption & bioavailability. –  – Irritation of rectal mucosa.Irritation of rectal mucosa.

 –  – Inconvenience.Inconvenience.

FormulationFormulationEnema or suppositoryEnema or suppository

e.g. aminophyllinee.g. aminophylline -- phenobarbitone.phenobarbitone.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 35/49

Intradermal (I.D.)Intradermal (I.D.)

Subcutaneous (S.C.)Subcutaneous (S.C.)

Intramuscular (I.M.)Intramuscular (I.M.)

Intravenous (I.V.)Intravenous (I.V.)

IntraIntra--arterial (I.A.)arterial (I.A.)

Intrathecal (I.T.) (Intrathecal (I.T.) (subarachnoidsubarachnoid space )space )

Intraperitoneal (I.P.) (peritoneum)Intraperitoneal (I.P.) (peritoneum)

IntraIntra -- articular articular ((SynovialSynovial fluids)fluids)

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 36/49

Intradermal InjectionIntradermal Injection

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 37/49

Intradermal InjectionIntradermal Injection

Between dermis & epidermis ( 0.1 ml ).Between dermis & epidermis ( 0.1 ml ). VaccinationsVaccinations--Sensitivity test.Sensitivity test.

Subcutaneous InjectionSubcutaneous Injection

Under the skin ( 0.1 mlUnder the skin ( 0.1 ml  – – 1 ml ).1 ml ).

Sustained release effect. e.g. insulinSustained release effect. e.g. insulin

zinc preparationzinc preparation

Intramuscular InjectionIntramuscular Injection

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 38/49

Intramuscular InjectionIntramuscular Injection

Larger amount of fluid (3Larger amount of fluid (3--5 ml).5 ml).  Avoid first Avoid first--pass metabolism.pass metabolism.

Onset of action more rapid than oral.Onset of action more rapid than oral. Prolonged duration of actionProlonged duration of action

Solubility of drug is not important.Solubility of drug is not important. Used for Oily preparation.Used for Oily preparation.

DisadvantagesDisadvantages

PainPain – – Abscess Abscess – –Tissue necrosis.Tissue necrosis.

Intravenous (I V )Intravenous (I V )

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 39/49

Intravenous (I.V.)Intravenous (I.V.)

 Advantages Advantages –  – The most rapid absorption.The most rapid absorption.

 –  – RapidRapid effect ( in emergency ).effect ( in emergency ). –  – High bioavailability (100%)High bioavailability (100%)

 –  – 

No destruction by GIT.No destruction by GIT.

 –  – No gastric irritation.No gastric irritation.

 –  – No First pass metabolism.No First pass metabolism.

 –  – No foodNo food--drug interaction.drug interaction.

 –  – Used in coma, convulsionUsed in coma, convulsion

 –  – Used for irritant drugs.Used for irritant drugs.

DisadvantagesDisadvantages

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 40/49

DisadvantagesDisadvantages

 –  – Only water soluble drugs (clear solutionOnly water soluble drugs (clear solutionshould be given).should be given).

 –  –  Anaphylaxis. Anaphylaxis.

 –  – Infection e.g. Viral hepatitis.Infection e.g. Viral hepatitis.

 –  – Thrombophlebitis.Thrombophlebitis.

 –  – Sterilization.Sterilization. –  – Pain at site of injection.Pain at site of injection.

 –  – Needs skill & Training.Needs skill & Training.

 –  – More expensive.More expensive.

Intraperitoneal InjectionIntraperitoneal Injection

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 41/49

Intraperitoneal InjectionIntraperitoneal Injection

Dialysis e.g. rabies vaccine.Dialysis e.g. rabies vaccine.

Intracardiac InjectionIntracardiac InjectionIn cardiac arrest e.g epinephrine.In cardiac arrest e.g epinephrine.

IntraIntra-arterial Injectionarterial Injection

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 42/49

IntraIntra--arterial Injectionarterial Injection

DiagnosisDiagnosis arteriography.arteriography. TreatmentTreatment dissolution ofdissolution of

coronary thrombosis.coronary thrombosis.

IntraIntra--thecalthecal InjectionInjection CNS infections.CNS infections.

Spinal anesthesia.Spinal anesthesia. Drugs that do not cross BBB.Drugs that do not cross BBB.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 43/49

Topical:Topical:

 –  –  Skin (Skin (percutaneouspercutaneous).).adhesive plastersadhesive plasters

 –  –  Ear.Ear. –  –  Nose.Nose.

 –  –  Respiratory tract (Inhalation)Respiratory tract (Inhalation) –  –  Eye.Eye.

 –  –  VaginaVagina

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 44/49

Provide local action.Provide local action.

Lipid soluble drugs.Lipid soluble drugs.

Prolonged drug action.Prolonged drug action.

 Avoids first pass metabolism. Avoids first pass metabolism.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 45/49

Local action in respiratory tract.Local action in respiratory tract.

Rapid effect due to large surface areaRapid effect due to large surface area

Inhalation anesthetics & bronchodilators.Inhalation anesthetics & bronchodilators.

Drugs given asDrugs given as

Gases.Gases.

Volatile liquids e.g. halothaneVolatile liquids e.g. halothane Solution ( aerosol,Solution ( aerosol, nebulizer nebulizer ))

powder (very fine).powder (very fine). NOT irritant.NOT irritant.

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 46/49

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 47/49

Is the fraction of unchanged drug thatIs the fraction of unchanged drug thatenters systemic circulation afterenters systemic circulation after

administration and becomes available foradministration and becomes available for

biological effect.biological effect.

It may be less than the dose (unity).It may be less than the dose (unity).

I.V. provides 100% bioavailability.I.V. provides 100% bioavailability.

Factors Affecting BioavailabilityFactors Affecting Bioavailability

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 48/49

g y

Molecular Weight.Molecular Weight.

Lipid/Water Partition Coefficient.Lipid/Water Partition Coefficient.

Pka.Pka.

Drug Formulation.Drug Formulation.First pass metabolismFirst pass metabolism

pH of gut.pH of gut.

Rate of gastric emptying.Rate of gastric emptying.

Intestinal motility (Transit Time).Intestinal motility (Transit Time).

Surface area available for absorption.Surface area available for absorption.Drug interactionsDrug interactions

FoodFood

FoodFood

8/20/2019 GENERAL PHARMACOLOGY -Part 1.pdf

http://slidepdf.com/reader/full/general-pharmacology-part-1pdf 49/49

Reduces absorptionReduces absorptionaspirin, penicillin V,aspirin, penicillin V,

tetracycline, erythromycin.tetracycline, erythromycin.

Increases absorptionIncreases absorption

PropranololPropranolol , diazepam,, diazepam, dicoumaroldicoumarol..